Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Glioblastoma Multiforme, Adult: early-phase trial registry
8 of 10 indexed Glioblastoma Multiforme, Adult trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,724 of 28,707 conditions by registered trial count.
10 US clinical trials · 8 currently recruiting · #1,724 of 28,707 conditions by registered trial count
Glioblastoma Multiforme, Adult: 10 US clinical trials tracked, 8 recruiting.
Glioblastoma Multiforme, Adult is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Jasper Gerritsen, running 4 of these trials.
Enrollment posture brief
Registry condition glioblastoma-multiforme-adult
OPEN 8 | RECR 80% | LATE 1 | EARLY 4 | RANK #1724 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Ablation (80% recruiting · 5 trials)
Glioblastoma Multiforme, Adult lists 8 open slots (80% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Glioblastoma Multiforme, Adult on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Glioblastoma Multiforme, Adult is recruiting above its size-band peers.
8 of 10 indexed trials (80%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Glioblastoma Multiforme, Adult research.
Jasper Gerritsen accounts for 4 of 10 trials (40%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical Glioblastoma Multiforme, Adult enrolment sits around 432 participants.
Median target enrolment is 432 among the 10 trials that report a genuine target (sentinel values excluded). 3 of those (30%) plan for fewer than 100 participants.
-
Glioblastoma Multiforme, Adult splits between interventional and observational designs.
6 interventional and 4 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
10 total, page 1 of 1
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
Jasper Gerritsen
NCT06146738
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Jasper Gerritsen
NCT06118723
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Jasper Gerritsen
NCT06146725
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Jasper Gerritsen
NCT06283927
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
Northwell Health
NCT05271240
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Baptist Health South Florida
NCT06991101
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Northwell Health
NCT05954858
hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
Leland Metheny
NCT05052957
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
CNS Pharmaceuticals
NCT04762069
Study of Pamiparib in Newly Diagnosed and rGBM
Nader Sanai
NCT04614909
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Glioblastoma Multiforme, Adult records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Glioblastoma Multiforme, Adult trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Glioblastoma Multiforme, Adult page
10 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Glioblastoma Multiforme, Adult trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Jasper Gerritsen sponsors the most Glioblastoma Multiforme, Adult trials on record, review their full trial history before evaluating a specific study. See Jasper Gerritsen's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Glioblastoma Multiforme, Adult condition card totals 10 registered trials; most-linked intervention Temozolomide; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.